The markets extended its losses during the midday with the Dow dropping 76 point to 15,374 over disappointing earnings. Nasdaq lost 6 points to 3677.
On the upside
Avanir Pharmaceuticals (Nasdaq: AVNR) settled its patent suit against Sandoz by granting rights for Sandoz to begin selling a generic version of Avanir’s Nuedexta on July 30, 2026.
Rising gold prices lifted shares of Gold Fields (NYSE: GFI), Harmony Gold (NYSE: HMY), Iamgold (NYSE: IAG), Kinross Gold (NYSE: KGC) and Newmont Mining (NYSE: NEM).
JinkoSolar (NYSE: JKS) reversed year ago losses to post a profit for the second quarter.
On the downside
A Seeking Alpha contributor raised bankruptcy concerns for Biolase (Nasdaq: BIOL).
ZaZa Energy (Nasdaq: ZAZA) widened second quarter losses as revenue plunged
TheExOne (Nasdaq: XONE) reported a larger than expected loss for the second quarter.
In the broad market, declining issues outpaced advancers by a margin of more than 5 to 3 on the NYSE and by nearly 5 to 4 on Nasdaq. The broader S&P 500 lost 6 points to 1687.
